Market Cap
$31.60 Billion
USD as of Jan. 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$215.98 B |
![]() |
$190.92 B |
![]() |
$55.11 B |
![]() |
$44.42 B |
![]() |
$44.32 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
Illumina, Inc. is a biotechnology company specialized in DNA sequencing. It develops, manufactures, and markets genetic and biological analysis systems dedicated to the markets of gene sequencing, genotyping and gene expression, and proteomics. Thanks to its products, Illumina has been able to dramatically reduce the cost of human genome sequencing.
Illumina, Inc. has the following listings and related stock indices.
Stock: NASDAQ: ILMN
Stock: BMV: ILMN
Stock: Bovespa: I1LM34
Stock: FSX: ILU
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.